From ACC 2024 – Laura Ross, PA-C: HeartBeet Clinic Offers Efficient, Reimbursable Avenue for Improving CV Risk Factors
From ACC 2024 – Laura Ross, PA-C: HeartBeet Clinic Offers Efficient, Reimbursable Avenue for Improving CV Risk Factors New data from the American College of Cardiology 2024 (ACC.24) Annual Scientific Session provide insight into the creation and reimbursement process for group visits to improve cardiovascular risk factors and lifestyle education. Dubbed the HeartBeet Clinic, the program leverages a food […]
Broadcasting from ACC 2024 – Ankeet Bhatt, MD, MBA: Sacubitril/Valsartan vs ACEi/ARB in de novo HFmrEF/HFpEF
Broadcasting from ACC 2024 – Ankeet Bhatt, MD, MBA: Sacubitril/Valsartan vs ACEi/ARB in de novo HFmrEF/HFpEF A comparative effectiveness analysis of data from the Optum Electronic Health Record dataset provides insight into the benefit of sacubitril/valsartan (Entresto) relative to angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) in patients with newly diagnosed heart failure with mildly reduced […]
Newscasting from ACC 2024 – Safia Chatur, MD: Sacubitril/Valsartan Offers Benefit in HFrEF Across New KDIGO Risk Classes
Newscasting from ACC 2024 – Safia Chatur, MD: Sacubitril/Valsartan Offers Benefit in HFrEF Across New KDIGO Risk Classes An analysis of data from PARADIGM-HF suggests sacubitril/valsartan (Entresto) provided consistent benefit across the spectrum of renal impairment among patients with heart failure with reduced ejection fraction (HFrEF). Presented at the American College of Cardiology 2024 (ACC.24) Annual Scientific […]
Reporting from ACC 2024 – Ankeet Bhatt, MD, MBA: NUDGE-FLU Analysis in Patients With and Without Myocardial Infarction
Reporting from ACC 2024 – Ankeet Bhatt, MD, MBA: NUDGE-FLU Analysis in Patients With and Without Myocardial Infarction Data from an analysis of the landmark NUDGE-FLU analysis offers insight into the effects of the study’s cardiovascular gains nudge on influenza vaccine uptake and outcomes based on history of acute myocardial infarction. Presented by Ankeet Bhatt, MD, […]
From ACC 2024: Understanding Trends in Hypertrophic Cardiomyopathy-Related ED Visits, with Ahmad Masri, MD, MS
From ACC 2024: Understanding Trends in Hypertrophic Cardiomyopathy-Related ED Visits, with Ahmad Masri, MD, MS Insights from an analysis of the Nationwide Emergency Department Sample (NEDS) from 2006 through 2019 provides a snapshot of trends in emergency department visits among patients with hypertrophic cardiomyopathy (HCM) in the US. Presented at the American College of Cardiology 2024 (ACC.24) Annual […]
Newly reported from ACC 2024 – Sara Saberi, MD: FOREST-HCM Data Demonstrates Long-Term Effects of Aficamten
Newly reported from ACC 2024 – Sara Saberi, MD: FOREST-HCM Data Demonstrates Long-Term Effects of Aficamten Data from a 46-person cohort with 1 year of follow-up from the FOREST-HCM trial provides clinicians with further insight into the long-term effects of aficamten in patients with hypertrophic cardiomyopathy. Presented at the American College of Cardiology 2024 (ACC.24) Annual Scientific […]
ACC.24 Clinical Trials Recap, with Deepak Bhatt, MD, MPH, MBA
ACC.24 Clinical Trials Recap, with Deepak Bhatt, MD, MPH, MBA Evidenced by the more than 17,000 attendees, the American College of Cardiology 2024 (ACC.24) Annual Scientific Session served as a showcase for the latest in clinically impactful advancements for the cardiology community. Although the sheer number of attendees serves as a testimony to the field’s seat at […]
Experts’ Perspectives: Advancements in Cardiomyopathy at ACC.24
Experts’ Perspectives: Advancements in Cardiomyopathy at ACC.24 In recent years, advancements in the treatment of cardiomyopathies have captivated the cardiology. However, experts and opinion leaders in cardiomyopathy are quick to remind others this progress was not overnight and comes as the result of tireless efforts by colleagues and their predecessors dating back decades. In the […]
Broadcasted from ACC 2024: Web App Could Improve Statin Therapy Without Need for Clinician Prescription
Broadcasted from ACC 2024: Web App Could Improve Statin Therapy Without Need for Clinician Prescription A study examines use of a web application to improve access to nonprescription statin therapy highlights the potential of digital interventions in improving population-level health. Results of the 6-month prospective study indicate use of the Technology Assisted Self-Selection (TASS) web application, which […]
ACC.24 Case Report: Leadless Pacemaker Extractions, with José López, MD
ACC.24 Case Report: Leadless Pacemaker Extractions, with José López, MD A study detailing a case series is offering clinicians additional perspective into an evolving area: leadless pacemaker extraction. Presented by at the American College of Cardiology 2024 (ACC.24) Annual Scientific Sessions on the 8-year anniversary of the FDA’s first approval for a leadless pacemaker, the study details 2 cases […]
